Predicting Calcium Oxalate Kidney Stones Using Clinical and Gut Microbiome Data

Overview

This study analyzed clinical and gut microbiome factors in 180 Chinese patients to predict calcium oxalate nephrolithiasis. Using 16S rRNA sequencing and machine learning, random forest models achieved the best predictive accuracy with AUCs up to 0.763 based on three key bacterial genera.

Background

Nephrolithiasis, particularly calcium oxalate stones, is a prevalent urological condition with increasing incidence. Stone formation is influenced by urinary oxalate concentration and citrate levels, which affect crystallization processes. The gut microbiota plays a role in maintaining metabolic homeostasis and may influence stone pathogenesis through metabolites like short-chain fatty acids that modulate oxidative stress and inflammation. Machine learning approaches offer potential for improved prediction of kidney stone risk by integrating microbiome and clinical data.

Data Highlights

OTUs identified: 5868; Genera selected by LEfSe: 243; Genera selected by HFE: 14; Common genera used for prediction: 3 (g__Flavobacterium, g__Rhodobacter, g__Gordonia)

Predictive model AUC range across eight algorithms using three genera: 0.682 to 0.763

Key Findings

• Calcium oxalate stones constitute approximately 80% of kidney stones and are linked to elevated urinary oxalate levels.
• Gut microbiota composition differs significantly between kidney stone patients and controls, with specific genera identified as potential biomarkers.
• Three bacterial genera (Flavobacterium, Rhodobacter, Gordonia) were consistently selected by two feature selection methods (LEfSe and HFE) as predictive features.
• Random forest machine learning models outperformed other algorithms in predicting calcium oxalate stone occurrence, achieving the highest average AUC in cross-validation.
• The study included 180 Chinese patients, providing a population-specific predictive model with validation on an independent cohort.

Clinical Implications

Integrating gut microbiome profiling with clinical data can enhance risk stratification for calcium oxalate nephrolithiasis. Random forest models using select bacterial genera may aid in early identification of patients at risk, potentially guiding preventive strategies. Further validation and incorporation into clinical workflows could improve personalized management of kidney stone disease.

Conclusion

This study demonstrates that combining clinical and gut microbiome factors with machine learning, particularly random forest algorithms, can effectively predict calcium oxalate kidney stone formation in Chinese patients. Identified microbial biomarkers offer promising targets for future diagnostic and therapeutic approaches.

References

1. Huang et al. 2021 -- Short-chain fatty acids inhibit oxidative stress and inflammation in kidney cells
2. Wu et al. 2022 -- Microbiome biomarkers and prediction of kidney stone recurrence
3. LEfSe and HFE methods -- Feature selection in microbiome studies